CRMD logo

CorMedix (CRMD) Cash From Operations

Annual CFO

-$38.41 M
-$14.05 M-57.70%

December 31, 2023


Summary


Performance

CRMD Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCRMDcash flowmetrics:

Quarterly CFO

-$13.65 M
+$390.00 K+2.78%

September 30, 2024


Summary


Performance

CRMD Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCRMDcash flowmetrics:

TTM CFO

-$55.75 M
-$4.95 M-9.75%

September 30, 2024


Summary


Performance

CRMD TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCRMDcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

CRMD Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-57.7%-27.0%-45.1%
3 y3 years-74.8%-121.8%-128.9%
5 y5 years-62.1%-341.5%-142.1%

CRMD Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-81.6%at low-149.9%+21.1%-163.5%at low
5 y5-year-155.2%at low-1709.4%+21.1%-270.4%at low
alltimeall time-1689.4%at low-8397.8%+21.1%<-9999.0%at low

CorMedix Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$13.65 M(-2.8%)
-$55.75 M(+9.8%)
Jun 2024
-
-$14.04 M(-18.9%)
-$50.79 M(+12.1%)
Mar 2024
-
-$17.31 M(+61.1%)
-$45.33 M(+18.0%)
Dec 2023
-$38.41 M(+57.7%)
-$10.75 M(+23.5%)
-$38.41 M(+13.6%)
Sep 2023
-
-$8.70 M(+1.5%)
-$33.82 M(+8.7%)
Jun 2023
-
-$8.57 M(-17.5%)
-$31.12 M(+11.1%)
Mar 2023
-
-$10.39 M(+68.9%)
-$28.01 M(+15.0%)
Dec 2022
-$24.36 M(+15.1%)
-$6.15 M(+2.7%)
-$24.36 M(+1.2%)
Sep 2022
-
-$6.00 M(+9.8%)
-$24.07 M(+2.1%)
Jun 2022
-
-$5.46 M(-19.0%)
-$23.58 M(+11.2%)
Mar 2022
-
-$6.74 M(+14.9%)
-$21.21 M(+0.3%)
Dec 2021
-$21.16 M(-3.7%)
-$5.87 M(+6.6%)
-$21.16 M(-0.3%)
Sep 2021
-
-$5.50 M(+78.0%)
-$21.22 M(-7.9%)
Jun 2021
-
-$3.09 M(-53.8%)
-$23.03 M(+11.3%)
Mar 2021
-
-$6.69 M(+12.8%)
-$20.69 M(-5.8%)
Dec 2020
-$21.97 M(+45.9%)
-$5.93 M(-18.9%)
-$21.97 M(+10.3%)
Sep 2020
-
-$7.31 M(+869.4%)
-$19.92 M(+20.2%)
Jun 2020
-
-$754.40 K(-90.5%)
-$16.57 M(+5.9%)
Mar 2020
-
-$7.97 M(+105.1%)
-$15.65 M(+4.0%)
Dec 2019
-$15.05 M(-36.5%)
-$3.88 M(-2.0%)
-$15.05 M(-18.1%)
Sep 2019
-
-$3.96 M(-2509.9%)
-$18.37 M(-5.9%)
Jun 2019
-
$164.50 K(-102.2%)
-$19.51 M(-18.7%)
Mar 2019
-
-$7.37 M(+2.3%)
-$24.01 M(+1.3%)
Dec 2018
-$23.70 M(-17.1%)
-$7.20 M(+40.9%)
-$23.70 M(-0.3%)
Sep 2018
-
-$5.11 M(+17.9%)
-$23.78 M(-6.6%)
Jun 2018
-
-$4.34 M(-38.5%)
-$25.47 M(-11.8%)
Mar 2018
-
-$7.05 M(-3.1%)
-$28.88 M(+1.0%)
Dec 2017
-$28.59 M(+28.4%)
-$7.28 M(+7.0%)
-$28.59 M(+2.8%)
Sep 2017
-
-$6.80 M(-12.3%)
-$27.81 M(+0.9%)
Jun 2017
-
-$7.75 M(+14.7%)
-$27.56 M(+16.9%)
Mar 2017
-
-$6.76 M(+4.0%)
-$23.57 M(+5.9%)
DateAnnualQuarterlyTTM
Dec 2016
-$22.27 M(+77.7%)
-$6.50 M(-0.8%)
-$22.27 M(+14.8%)
Sep 2016
-
-$6.55 M(+73.8%)
-$19.40 M(+22.8%)
Jun 2016
-
-$3.77 M(-30.9%)
-$15.80 M(+1.1%)
Mar 2016
-
-$5.45 M(+49.9%)
-$15.63 M(+24.8%)
Dec 2015
-$12.53 M(+98.2%)
-$3.64 M(+23.4%)
-$12.53 M(+19.7%)
Sep 2015
-
-$2.94 M(-18.2%)
-$10.47 M(+12.1%)
Jun 2015
-
-$3.60 M(+53.3%)
-$9.33 M(+28.9%)
Mar 2015
-
-$2.35 M(+49.2%)
-$7.24 M(+14.5%)
Dec 2014
-$6.32 M(+74.7%)
-$1.57 M(-13.1%)
-$6.32 M(+11.5%)
Sep 2014
-
-$1.81 M(+20.3%)
-$5.67 M(+5.5%)
Jun 2014
-
-$1.51 M(+5.4%)
-$5.38 M(+21.4%)
Mar 2014
-
-$1.43 M(+54.8%)
-$4.43 M(+22.4%)
Dec 2013
-$3.62 M(+59.0%)
-$923.20 K(-39.2%)
-$3.62 M(+12.3%)
Sep 2013
-
-$1.52 M(+171.4%)
-$3.22 M(+35.6%)
Jun 2013
-
-$559.30 K(-9.5%)
-$2.38 M(-14.0%)
Mar 2013
-
-$617.80 K(+16.9%)
-$2.76 M(+21.4%)
Dec 2012
-$2.28 M(-63.8%)
-$528.30 K(-21.3%)
-$2.28 M(-14.2%)
Sep 2012
-
-$671.60 K(-29.0%)
-$2.65 M(-30.7%)
Jun 2012
-
-$946.30 K(+627.4%)
-$3.83 M(-18.7%)
Mar 2012
-
-$130.10 K(-85.6%)
-$4.71 M(-25.2%)
Dec 2011
-$6.30 M(+71.6%)
-$904.60 K(-51.1%)
-$6.30 M(-5.0%)
Sep 2011
-
-$1.85 M(+1.3%)
-$6.63 M(+13.5%)
Jun 2011
-
-$1.82 M(+6.1%)
-$5.84 M(+13.3%)
Mar 2011
-
-$1.72 M(+38.8%)
-$5.16 M(+40.6%)
Dec 2010
-$3.67 M(+70.9%)
-$1.24 M(+16.9%)
-$3.67 M(+17.8%)
Sep 2010
-
-$1.06 M(-6.9%)
-$3.12 M(+33.7%)
Jun 2010
-
-$1.14 M(+393.3%)
-$2.33 M(+26.9%)
Mar 2010
-
-$230.90 K(-66.3%)
-$1.84 M(-14.5%)
Dec 2009
-$2.15 M
-$685.20 K(+149.5%)
-$2.15 M(+46.9%)
Sep 2009
-
-$274.60 K(-57.5%)
-$1.46 M(+23.1%)
Jun 2009
-
-$645.50 K(+19.3%)
-$1.19 M(+119.3%)
Mar 2009
-
-$541.20 K
-$541.20 K

FAQ

  • What is CorMedix annual cash flow from operations?
  • What is the all time high annual CFO for CorMedix?
  • What is CorMedix annual CFO year-on-year change?
  • What is CorMedix quarterly cash flow from operations?
  • What is the all time high quarterly CFO for CorMedix?
  • What is CorMedix quarterly CFO year-on-year change?
  • What is CorMedix TTM cash flow from operations?
  • What is the all time high TTM CFO for CorMedix?
  • What is CorMedix TTM CFO year-on-year change?

What is CorMedix annual cash flow from operations?

The current annual CFO of CRMD is -$38.41 M

What is the all time high annual CFO for CorMedix?

CorMedix all-time high annual cash flow from operations is -$2.15 M

What is CorMedix annual CFO year-on-year change?

Over the past year, CRMD annual cash flow from operations has changed by -$14.05 M (-57.70%)

What is CorMedix quarterly cash flow from operations?

The current quarterly CFO of CRMD is -$13.65 M

What is the all time high quarterly CFO for CorMedix?

CorMedix all-time high quarterly cash flow from operations is $164.50 K

What is CorMedix quarterly CFO year-on-year change?

Over the past year, CRMD quarterly cash flow from operations has changed by -$2.90 M (-27.03%)

What is CorMedix TTM cash flow from operations?

The current TTM CFO of CRMD is -$55.75 M

What is the all time high TTM CFO for CorMedix?

CorMedix all-time high TTM cash flow from operations is -$541.20 K

What is CorMedix TTM CFO year-on-year change?

Over the past year, CRMD TTM cash flow from operations has changed by -$17.34 M (-45.14%)